Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices
Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunat...
Gespeichert in:
Veröffentlicht in: | Mayo Clinic proceedings 2024-07, Vol.99 (7), p.1127-1141 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1141 |
---|---|
container_issue | 7 |
container_start_page | 1127 |
container_title | Mayo Clinic proceedings |
container_volume | 99 |
creator | Khan, Aliya A. Slart, Riemer H.J.A. Ali, Dalal S. Bock, Oliver Carey, John J. Camacho, Pauline Engelke, Klaus Erba, Paola A. Harvey, Nicholas C. Lems, Willem F. Morgan, Sarah Moseley, Kendall F. O’Brien, Christopher Probyn, Linda Punda, Marija Richmond, Bradford Schousboe, John T. Shuhart, Christopher Ward, Kate A. Lewiecki, E. Michael |
description | Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting. |
doi_str_mv | 10.1016/j.mayocp.2024.01.011 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3075701832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A804160634</galeid><els_id>S0025619624000478</els_id><sourcerecordid>A804160634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</originalsourceid><addsrcrecordid>eNp9kVuLFDEQhRtR3HH1H4jkSXzYGSuX6Z72QRj35sLCCir6FmrSlZmM3cmYpBfWX2_GWUVfJAWB4jtVhzpV9ZzDjAOvX29nA94Fs5sJEGoGvBR_UE14q8R0Plf1w2oCIObTmrf1UfUkpS0ANG2rHldHctHWoNpmUv24SZnCLsSQnWEXEU0eI6U37Mzh2ofk0gk7v8V-xOyCP2HoO_bRrb2zzqA3VCRhYHlD7Mpniv4Xhj37EuI359fsMoZxx4JnZ1-X7B2lzD7sdzhD6Wn1yGKf6Nn9f1x9vjj_dPp-en1zeXW6vJ4aWYs8JbGqobFzKQ1KqzqrVo2wANgaQZ0QoBC7Bq0RUlop20aJGnFlEFadbRZGHlevDnN3MXwfiwU9uGSo79FTGJOW0Mwb4AspCjo7oGvsSTtvQy5uy-tocCZ4sq70lwtQvIZaqiJ4-ZdgQ9jnTQr9uL9C-hdUB9DEkFIkq3fRDRjvNAe9z1Nv9SFPvc9TAy_Fi-zFvfdxNVD3R_Q7wAK8PQBULnjrKOpkHJVgOhfJZN0F9_8NPwHvebPR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3075701832</pqid></control><display><type>article</type><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael</creator><creatorcontrib>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael ; International Working Group on DXA Best Practices</creatorcontrib><description>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</description><identifier>ISSN: 0025-6196</identifier><identifier>ISSN: 1942-5546</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2024.01.011</identifier><identifier>PMID: 38960497</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Absorptiometry, Photon - methods ; Biotechnology industry ; Bone Density ; Canada ; Care and treatment ; Denosumab ; Diagnosis ; Female ; Health aspects ; Humans ; Mortality ; Osteoporosis ; Osteoporosis - diagnosis ; Osteoporosis - diagnostic imaging ; Osteoporotic Fractures - diagnosis ; Osteoporotic Fractures - diagnostic imaging ; Osteoporotic Fractures - prevention & control ; Practice Guidelines as Topic ; Risk Factors ; United States</subject><ispartof>Mayo Clinic proceedings, 2024-07, Vol.99 (7), p.1127-1141</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2024 Elsevier, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</citedby><cites>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</cites><orcidid>0000-0002-2669-4173 ; 0000-0002-8194-2512 ; 0000-0002-6885-3953 ; 0000-0001-9875-4123 ; 0000-0001-7034-6750 ; 0000-0003-3733-8956 ; 0000-0002-9329-0750 ; 0000-0003-2026-9587 ; 0000-0002-4645-9170 ; 0000-0002-5565-1164 ; 0000-0003-2500-2312 ; 0000-0002-5378-5548 ; 0000-0001-7292-2328</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38960497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Aliya A.</creatorcontrib><creatorcontrib>Slart, Riemer H.J.A.</creatorcontrib><creatorcontrib>Ali, Dalal S.</creatorcontrib><creatorcontrib>Bock, Oliver</creatorcontrib><creatorcontrib>Carey, John J.</creatorcontrib><creatorcontrib>Camacho, Pauline</creatorcontrib><creatorcontrib>Engelke, Klaus</creatorcontrib><creatorcontrib>Erba, Paola A.</creatorcontrib><creatorcontrib>Harvey, Nicholas C.</creatorcontrib><creatorcontrib>Lems, Willem F.</creatorcontrib><creatorcontrib>Morgan, Sarah</creatorcontrib><creatorcontrib>Moseley, Kendall F.</creatorcontrib><creatorcontrib>O’Brien, Christopher</creatorcontrib><creatorcontrib>Probyn, Linda</creatorcontrib><creatorcontrib>Punda, Marija</creatorcontrib><creatorcontrib>Richmond, Bradford</creatorcontrib><creatorcontrib>Schousboe, John T.</creatorcontrib><creatorcontrib>Shuhart, Christopher</creatorcontrib><creatorcontrib>Ward, Kate A.</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>International Working Group on DXA Best Practices</creatorcontrib><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</description><subject>Absorptiometry, Photon - methods</subject><subject>Biotechnology industry</subject><subject>Bone Density</subject><subject>Canada</subject><subject>Care and treatment</subject><subject>Denosumab</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Mortality</subject><subject>Osteoporosis</subject><subject>Osteoporosis - diagnosis</subject><subject>Osteoporosis - diagnostic imaging</subject><subject>Osteoporotic Fractures - diagnosis</subject><subject>Osteoporotic Fractures - diagnostic imaging</subject><subject>Osteoporotic Fractures - prevention & control</subject><subject>Practice Guidelines as Topic</subject><subject>Risk Factors</subject><subject>United States</subject><issn>0025-6196</issn><issn>1942-5546</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVuLFDEQhRtR3HH1H4jkSXzYGSuX6Z72QRj35sLCCir6FmrSlZmM3cmYpBfWX2_GWUVfJAWB4jtVhzpV9ZzDjAOvX29nA94Fs5sJEGoGvBR_UE14q8R0Plf1w2oCIObTmrf1UfUkpS0ANG2rHldHctHWoNpmUv24SZnCLsSQnWEXEU0eI6U37Mzh2ofk0gk7v8V-xOyCP2HoO_bRrb2zzqA3VCRhYHlD7Mpniv4Xhj37EuI359fsMoZxx4JnZ1-X7B2lzD7sdzhD6Wn1yGKf6Nn9f1x9vjj_dPp-en1zeXW6vJ4aWYs8JbGqobFzKQ1KqzqrVo2wANgaQZ0QoBC7Bq0RUlop20aJGnFlEFadbRZGHlevDnN3MXwfiwU9uGSo79FTGJOW0Mwb4AspCjo7oGvsSTtvQy5uy-tocCZ4sq70lwtQvIZaqiJ4-ZdgQ9jnTQr9uL9C-hdUB9DEkFIkq3fRDRjvNAe9z1Nv9SFPvc9TAy_Fi-zFvfdxNVD3R_Q7wAK8PQBULnjrKOpkHJVgOhfJZN0F9_8NPwHvebPR</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Khan, Aliya A.</creator><creator>Slart, Riemer H.J.A.</creator><creator>Ali, Dalal S.</creator><creator>Bock, Oliver</creator><creator>Carey, John J.</creator><creator>Camacho, Pauline</creator><creator>Engelke, Klaus</creator><creator>Erba, Paola A.</creator><creator>Harvey, Nicholas C.</creator><creator>Lems, Willem F.</creator><creator>Morgan, Sarah</creator><creator>Moseley, Kendall F.</creator><creator>O’Brien, Christopher</creator><creator>Probyn, Linda</creator><creator>Punda, Marija</creator><creator>Richmond, Bradford</creator><creator>Schousboe, John T.</creator><creator>Shuhart, Christopher</creator><creator>Ward, Kate A.</creator><creator>Lewiecki, E. Michael</creator><general>Elsevier Inc</general><general>Elsevier, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2669-4173</orcidid><orcidid>https://orcid.org/0000-0002-8194-2512</orcidid><orcidid>https://orcid.org/0000-0002-6885-3953</orcidid><orcidid>https://orcid.org/0000-0001-9875-4123</orcidid><orcidid>https://orcid.org/0000-0001-7034-6750</orcidid><orcidid>https://orcid.org/0000-0003-3733-8956</orcidid><orcidid>https://orcid.org/0000-0002-9329-0750</orcidid><orcidid>https://orcid.org/0000-0003-2026-9587</orcidid><orcidid>https://orcid.org/0000-0002-4645-9170</orcidid><orcidid>https://orcid.org/0000-0002-5565-1164</orcidid><orcidid>https://orcid.org/0000-0003-2500-2312</orcidid><orcidid>https://orcid.org/0000-0002-5378-5548</orcidid><orcidid>https://orcid.org/0000-0001-7292-2328</orcidid></search><sort><creationdate>202407</creationdate><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><author>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Absorptiometry, Photon - methods</topic><topic>Biotechnology industry</topic><topic>Bone Density</topic><topic>Canada</topic><topic>Care and treatment</topic><topic>Denosumab</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Mortality</topic><topic>Osteoporosis</topic><topic>Osteoporosis - diagnosis</topic><topic>Osteoporosis - diagnostic imaging</topic><topic>Osteoporotic Fractures - diagnosis</topic><topic>Osteoporotic Fractures - diagnostic imaging</topic><topic>Osteoporotic Fractures - prevention & control</topic><topic>Practice Guidelines as Topic</topic><topic>Risk Factors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Aliya A.</creatorcontrib><creatorcontrib>Slart, Riemer H.J.A.</creatorcontrib><creatorcontrib>Ali, Dalal S.</creatorcontrib><creatorcontrib>Bock, Oliver</creatorcontrib><creatorcontrib>Carey, John J.</creatorcontrib><creatorcontrib>Camacho, Pauline</creatorcontrib><creatorcontrib>Engelke, Klaus</creatorcontrib><creatorcontrib>Erba, Paola A.</creatorcontrib><creatorcontrib>Harvey, Nicholas C.</creatorcontrib><creatorcontrib>Lems, Willem F.</creatorcontrib><creatorcontrib>Morgan, Sarah</creatorcontrib><creatorcontrib>Moseley, Kendall F.</creatorcontrib><creatorcontrib>O’Brien, Christopher</creatorcontrib><creatorcontrib>Probyn, Linda</creatorcontrib><creatorcontrib>Punda, Marija</creatorcontrib><creatorcontrib>Richmond, Bradford</creatorcontrib><creatorcontrib>Schousboe, John T.</creatorcontrib><creatorcontrib>Shuhart, Christopher</creatorcontrib><creatorcontrib>Ward, Kate A.</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>International Working Group on DXA Best Practices</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Aliya A.</au><au>Slart, Riemer H.J.A.</au><au>Ali, Dalal S.</au><au>Bock, Oliver</au><au>Carey, John J.</au><au>Camacho, Pauline</au><au>Engelke, Klaus</au><au>Erba, Paola A.</au><au>Harvey, Nicholas C.</au><au>Lems, Willem F.</au><au>Morgan, Sarah</au><au>Moseley, Kendall F.</au><au>O’Brien, Christopher</au><au>Probyn, Linda</au><au>Punda, Marija</au><au>Richmond, Bradford</au><au>Schousboe, John T.</au><au>Shuhart, Christopher</au><au>Ward, Kate A.</au><au>Lewiecki, E. Michael</au><aucorp>International Working Group on DXA Best Practices</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2024-07</date><risdate>2024</risdate><volume>99</volume><issue>7</issue><spage>1127</spage><epage>1141</epage><pages>1127-1141</pages><issn>0025-6196</issn><issn>1942-5546</issn><eissn>1942-5546</eissn><abstract>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>38960497</pmid><doi>10.1016/j.mayocp.2024.01.011</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-2669-4173</orcidid><orcidid>https://orcid.org/0000-0002-8194-2512</orcidid><orcidid>https://orcid.org/0000-0002-6885-3953</orcidid><orcidid>https://orcid.org/0000-0001-9875-4123</orcidid><orcidid>https://orcid.org/0000-0001-7034-6750</orcidid><orcidid>https://orcid.org/0000-0003-3733-8956</orcidid><orcidid>https://orcid.org/0000-0002-9329-0750</orcidid><orcidid>https://orcid.org/0000-0003-2026-9587</orcidid><orcidid>https://orcid.org/0000-0002-4645-9170</orcidid><orcidid>https://orcid.org/0000-0002-5565-1164</orcidid><orcidid>https://orcid.org/0000-0003-2500-2312</orcidid><orcidid>https://orcid.org/0000-0002-5378-5548</orcidid><orcidid>https://orcid.org/0000-0001-7292-2328</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-6196 |
ispartof | Mayo Clinic proceedings, 2024-07, Vol.99 (7), p.1127-1141 |
issn | 0025-6196 1942-5546 1942-5546 |
language | eng |
recordid | cdi_proquest_miscellaneous_3075701832 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Absorptiometry, Photon - methods Biotechnology industry Bone Density Canada Care and treatment Denosumab Diagnosis Female Health aspects Humans Mortality Osteoporosis Osteoporosis - diagnosis Osteoporosis - diagnostic imaging Osteoporotic Fractures - diagnosis Osteoporotic Fractures - diagnostic imaging Osteoporotic Fractures - prevention & control Practice Guidelines as Topic Risk Factors United States |
title | Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A42%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoporotic%20Fractures:%20Diagnosis,%20Evaluation,%20and%20Significance%20From%20the%20International%20Working%20Group%20on%20DXA%20Best%20Practices&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Khan,%20Aliya%20A.&rft.aucorp=International%20Working%20Group%20on%20DXA%20Best%20Practices&rft.date=2024-07&rft.volume=99&rft.issue=7&rft.spage=1127&rft.epage=1141&rft.pages=1127-1141&rft.issn=0025-6196&rft.eissn=1942-5546&rft_id=info:doi/10.1016/j.mayocp.2024.01.011&rft_dat=%3Cgale_proqu%3EA804160634%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3075701832&rft_id=info:pmid/38960497&rft_galeid=A804160634&rft_els_id=S0025619624000478&rfr_iscdi=true |